Closure of Buy Back

Windlas Biotech has successfully completed its share buyback via a tender offer, repurchasing and extinguishing 4,70,000 equity shares at INR 1,000 per share, totaling **47.00 Cr**. The extinguishment was completed on May 18. This buyback reduced the total outstanding shares from 2.11 Cr to 2.06 Cr.

Post-buyback, the promoter shareholding has increased from 61.90% to 63.31%, reflecting a more consolidated ownership structure.